Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Tests

Showing 12 out of 208 results
Sânziana Foia in the lab with an image of Papcup, the new HPV test she has designed for cervical screening, on a laptop.

Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part.  Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part. 

by Sadaf Shafaghmotlagh | Analysis | 4 September 2024

4 September 2024

A woman reading a cancer information limit while waiting to see the doctor.

Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund. Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund.

by Tim Gunn | News | 15 August 2024

15 August 2024

Squamous epithelial cells of human cervix under the microscope view.
  • Health & Medicine
  • Science & Technology

70 years of progress in cervical cancer research

25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends. 25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends.

by Jacob Smith | In depth | 17 June 2024

17 June 2024

Visitors at the National Biomarker Centre

Today marks the opening of the Cancer Research UK National Biomarker Centre, a new state-of-the-art facility in Manchester which will help experts detect cancer at an earlier stage – when there are usually more treatment options available. Today marks the opening of the Cancer Research UK National Biomarker Centre, a new state-of-the-art facility in Manchester which will help experts detect cancer at an earlier stage – when there are usually more treatment options available.

by Amy Warnock | News | 14 June 2024

14 June 2024

A computer-generated images showing a DNA double-helix in a blood sample

Multi-cancer tests have the potential to detect multiple cancer types from a single sample. There's a lot to learn before we can use them. Multi-cancer tests have the potential to detect multiple cancer types from a single sample. There's a lot to learn before we can use them.

by Jessica Lloyd, Alice Brookes | In depth | 12 June 2024

12 June 2024

This entry is part 1 of 1 in the series Multi-cancer tests
Sample bottles in a lab

A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial. A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial.

by Tim Gunn | News | 1 June 2024

1 June 2024

A medical professional holding a tube containing a blood sample

Researchers in Manchester have developed CUPiD, a blood test that could transform the diagnostic journey of someone with cancer of unknown primary. Researchers in Manchester have developed CUPiD, a blood test that could transform the diagnostic journey of someone with cancer of unknown primary.

by Jacob Smith | In depth | 23 April 2024

23 April 2024

A man talking to a GP

Why isn’t there a screening programme for prostate cancer? Here, we take a look at some of the latest research into PSA testing to find out.  Why isn’t there a screening programme for prostate cancer? Here, we take a look at some of the latest research into PSA testing to find out. 

by Amy Warnock | Analysis | 6 April 2024

6 April 2024

A microscope image showing cells affected by Barrett's oesophagus, a precancer that can lead to oesophageal cancer.

For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.   For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.  

by Amy Warnock | Analysis | 9 February 2024

9 February 2024

Stained cervical cells viewed under the microscope

22-28 January is Cervical Cancer Prevention Week. To recognise that, we’ve compiled some of our most useful content on cervical cancer, from research in the lab to screening in the clinic, to get you up to date on how we can prevent cervical cancer. 22-28 January is Cervical Cancer Prevention Week. To recognise that, we’ve compiled some of our most useful content on cervical cancer, from research in the lab to screening in the clinic, to get you up to date on how we can prevent cervical cancer.

by Jacob Smith | Analysis | 22 January 2024

22 January 2024

An image of a capsule sponge, a test for Barrett's oesophagus and oesophageal cancer

Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year.  Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year. 

by Tim Gunn | Analysis | 11 January 2024

11 January 2024